Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
This seems more than sell the news.
from $13 to $8.5??.... I saw once with CVM similar shorts attacks.. then went back up.. Lets see
Hopefully my last add @ $9 will be ok.
Just got them before the halt.
Wonder why the sell off is happening.
I added some @ $9
is that shorts attack???
That’s some drop
Here ya go...
PDS Biotechnology Set to Join Russell Microcap® Index
June 28th
The set up looks great!
PDSB May 2021 Biz presentation.
https://www.pdsbiotech.com/images/pdf/presentation/2021/may/PDSB_Corporate_Overview_-_May_24_2021_v5.pdf
PDSB Website:
https://www.pdsbiotech.com
$PDSB
Shake shake. Taking out stops.
Do you think we get a PR before their presentation releasing the complete abstract? Gltu
The ASCO saved the best for last. I look forward to listing to everything Frank has to say Tuesday morning before market openes
PDS Biotechnology (NASDAQ:PDSB) had its price target raised by analysts at HC Wainwright from $8.00 to $20.00 on Wednesday. They now have a "buy" rating on the stock. They noted that the move was a valuation call.This represents a 56.5% upside from the current price of $12.78.
Great Post!
Careful bears shorting this one bears one of the best performing stocks of 2021 BOOMAGE!
Hi bears lol lmao.
https://i.pinimg.com/originals/58/80/ef/5880ef672981142ff41ded2c0c25782c.gif
$PDSB
ASCO Info...
Abstract Number: 2501
Abstract Title: Phase II evaluation of the triple combination of PDS0101, M9241, and bintrafusp alfa in patients with HPV 16 positive malignancies.
Presenting Author: Julius Strauss, MD, National Cancer Institute
Session: Developmental Therapeutics—Immunotherapy
Date: June 7, 2021
Time: 3:00 PM-6:00 PM EDT
The abstract will be available on Wednesday, May 19 at 5:00 PM EDT on ASCO.org.
877-407-3088 is the number to listen in as frank reviews the Results on Tuesday 6/8 at 8:am
https://pdsbiotech.com/investors/news-center/press-releases/press-releases1/113-2021-news/516-iotechnnouncesralresentationof0101ataby20210429
PDSB next few weeks and months and years ahead will be fun to be a key shareholder of this company.
ASCO next week!
$PDSB
Happy for you! I appreciate the heads up a few weeks ago. I got out after a 50% gain, didn't realize this thing had such long legs!!
Yes small Biotech companies like $PDSB & $HEPA with bleeding cutting edge technology and great management teams will make people fortunes.You can make book on that!
$PDSB
Based off what I've seen lately, I hope they short the dog $hit out of it hahahahahahaa
up 17.% today up 1300% from the 52 week low of $1.12
Shorting this stock would be the dumbest move of all time.
$PDSB
Just broke 13. Such a beast. With a little more volume anything is possible.
Another 52 Week High KABOOMAGE!
Beast mode 2.0
$PDSB
PDS Biotechnology Expands VERSATILE-002 study of PDS0101 and KEYTRUDA® in Advanced Head and Neck Cancer to Include Patients Who Have Failed Prior Treatment with Checkpoint Inhibitors
https://finance.yahoo.com/news/pds-biotechnology-expands-versatile-002-125300514.html
$PDSB
Check out the news. I can’t post the link from my phone. Nice
Should be getting confirmation from Brazil soon!
$PDSB
Thanks!
PDSB May 2021 Biz Presentation.
https://www.pdsbiotech.com/images/pdf/presentation/2021/may/PDSB_Corporate_Overview_-_May_24_2021_v5.pdf
PDSB website.
https://www.pdsbiotech.com/
52 week low 1.12
52 week high 12.46
Kaboomage
$PDSB
Thanks PDSB is a beast one the best performing biotech microcaps in the last 12 months. The sky is the limit here! I promised my girlfriend I would spend less time working. To all the longs at PDSB congrats greener pastures awaits us.
$PDSB
So happy to see you were away having fun and buying a house in paradise, congrats. When you went silent, I was concerned. Now that you are back, how about making PDS jump to $15 by this Friday and $30-40 by next Friday?
Nice to have you back. Congratulations on the new house.
Thank you Maui was great first getaway in over a year and finally bought my dream house in Maui.
PDS Biotech to Host Oncology R&D Day on June 16, 2021
https://www.globenewswire.com/news-release/2021/06/01/2239492/0/en/PDS-Biotech-to-Host-Oncology-R-D-Day-on-June-16-2021.html
$PDSB
Nice welcome back.
I like HEPA but playing that by way of the very low cost warrants CTRVW
Just got back from Maui with some of my PDSB & NVAX gains bought a second home ocean view 2.2 Million put a million down and I'm still holding 100k PDSB shares free and clear. Also found a new gem just started a position in HEPA & went long BB at 9.19 last week. Love the $20.00 upgrade today HCW
$PDSB
Just saw this. YAAAASSSSSS....That was quick hahahaha
WC Wainwright just uped it from $8 to $20.
I was nervous yesterday...but it looks like we're off to a good start
Sure looks that way. A very healthy sign. Diamond hands.
I don’t think so. It’s only given back about 100K shares. Remember, this ones tight
Correction. Was way over bought. RSI back down to 73. Ppl hopping for an entry
I guess today is the day of the sell off. XBI getting thrashed.
PDS Biotech to Host Oncology R&D Day on June 16, 2021
PDS Biotechnology Corporation (Nasdaq: PDSB), a clinical-stage immunotherapy company developing novel cancer therapies based on the Company’s proprietary Versamune® T-cell activating technology, today announced it will host an Oncology R&D Day for analysts, investors, and the scientific community from 8:00 – 10:00 AM ET on Wednesday, June 16th.
PDS Biotech’s Oncology R&D Day will focus on the Company’s advancements in its ongoing preclinical and clinical work and will feature presentations from:
Dr. Frank Bedu-Addo, President and CEO, PDS Biotech
Dr. Lauren V. Wood, Chief Medical Officer, PDS Biotech
Dr. Jeffrey Schlom, Chief of the Laboratory of Tumor Immunology and Biology, Center for Cancer Research, National Cancer Institute, National Institute of Health
Dr. Julius Strauss, Principal Investigator, Laboratory of Tumor Immunology and Biology, Center for Cancer Research, National Cancer Institute, National Institute of Health
Dr. Caroline Jochems, Staff Scientist, Laboratory of Tumor Immunology and Biology, Center for Cancer Research, National Cancer Institute, National Institute of Health
A copy of the presentations will be available on June 17th on the scientific presentations and publications page of PDS Biotech's website. Registration for PDS Biotech’s Oncology R&D Day is now open and a live webcast of the event will be available online in the investor relations section of the company's website at https://pdsbiotech.com/investors/news-center/events. A replay will be available on the company website for 90 days following the webcast.
Got it thank you !
Followers
|
49
|
Posters
|
|
Posts (Today)
|
0
|
Posts (Total)
|
1582
|
Created
|
06/17/20
|
Type
|
Free
|
Moderators |
https://pdsbiotech.com/images/pdf/presentation/2021/march/PDSB_Corporate_Overview_-_March_11_2021_FINAL_1.pdf ![]() |
DEVELOPING POWERFUL, SAFE, VERSATILE IMMUNOTHERAPIES |
![]() ![]() |
PDSB Versamune® T cell Platform. Our Versamune® platform trains the immune system to unleash a powerful targeted T-cell attack and could dramatically improve treatment and patient outcomes across the cancer spectrum. |
PDSB analyst coverage: |
SECOND GENERATION COVID-19 VACCINE PHASE 3 Q4 2021 PDSB $100.00 PRICE PER SHARE =2.2 BILLION MARKET CAP |
PDSB biz presentation 2021: PDSB White Paper: https://pdsbiotech.com/images/pdf/presentation/2021/Whitepaper-2021_v6.pdf PDSB Biotech preparing to initiate 3 CANCER Phase 2 clinical studies for lead candidate PDS0101: https://www.youtube.com/watch?v=iYZRmRmRtUI&t=2s OPPENHEIMER Annual Healthcare Conference MARCH 16TH 2021 https://wsw.com/webcast/oppenheimer9/register.aspx?conf=oppenheimer9&page=pdsb&url=https://wsw.com/webcast/oppenheimer9/pdsb/2708189 PDSB website: |
Volume | |
Day Range: | |
Bid Price | |
Ask Price | |
Last Trade Time: |